A New Solution for Double Chins
Men and women often complain of disliking their profile due to their undesirable "double chin" or fullness of their neck due to submental and submandibular fat deposits under the chin or jawline. This condition is usually associated with genetics, aging and/or weight gain. It may be seen in patients within their ideal weight. The appearance of neck convexity or fullness negatively impacts these individuals, and they are often perceived as heavy or older.
Many patients assume that surgery is the only option. Now, these unmet needs can be addressed using a non-surgical option with injections to destroy fat cells. Injection of deoxycholic acid into the submental fat causes a denaturation of the fat deposits and dissolves the fat ,which allows the body to absorb it. This results in non-surgical contouring and sculpting of the neck. It is a procedure that we along with many other clinics have performed with variable results using deoxycholic acid compounded from various pharmacies.
Deoxycholic acid is produced in the body and helps the body absorb fats. Deoxycholic acid is a cytolytic drug. When it is injected into fat cells, it destroys the cell membranes. Practitioners must be properly trained to inject deoxycholic acid. Accidental injection into surrounding tissue can cause destruction of those cells as well for instance surrounding muscle and nerve cells.
Deoxycholic acid will now be available for the first time as an FDA approved submental contouring injectable drug called Kybella. Kybella has undergone clinical studies for safety and effectiveness. Over 20 clinical trials with more than 1600 patients treated yielded high patient satisfaction. The anticipated arrival will be later this month. Kybella is the first and only approved non-surgical treatment for reduction of submental fullness or convexity.
An ideal candidate for the treatment of the "double chin" with Kybella is a patient within their ideal weight with fullness of the neck, which is resistant to diet and exercise. Practitioners can customize the number of treatments to their patients according to the amount of submental fat. Most patients will require 2-6 treatments. After desired reduction, patients usually will not require re-treatment. An anticipated concern may be residual skin laxity, but the inflammation caused by the Kybella may cause variable degrees of tightening, so a secondary tightening procedure may not be required after the series of injections.
The injections elicit minimal pain response, but due to inflammatory changes of the fat cells initial swelling post-injection can be expected and may last approximately 2-5 days, so some down time may be expected. Other adverse reactions may include bruising, pain, numbness, erythema or formation of small areas of firmness at or around the injection site. Also the area may remain slightly more sensitive to touch for several weeks. Most of the adverse reactions were reported to be mild.